Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.4400
0.00 (0.00%)
At close: Jan 30, 2026, 4:00 PM EST
0.4563
+0.0163 (3.70%)
After-hours: Jan 30, 2026, 7:47 PM EST
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $70.02 million as of January 30, 2026. Its market cap has decreased by -85.08% in one year.
Market Cap
70.02M
Enterprise Value
21.72M
1-Year Change
-85.08%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $70.02M, a decrease of -43.91%. That is a compound annual growth rate of -8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 70.02M | 5.59% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 80.25M |
| Atossa Therapeutics | 80.09M |
| ImageneBio | 78.82M |
| Pliant Therapeutics | 77.43M |
| PolyPid | 76.94M |
| Coeptis Therapeutics Holdings | 76.06M |
| Gain Therapeutics | 75.91M |
| ALX Oncology Holdings | 75.91M |